Stephanie Y.

Stephanie Y. is currently the Senior Vice President of Investor Relations and Corporate Communications at Bicycle Therapeutics, a position held since September 2023. Previously, Stephanie Y. served as Vice President of Communications and Investor Relations at Graphite Bio from 2021 to 2023, and as Executive Director of Investor Relations and Corporate Communications at Kronos Bio, Inc. in 2020. Additional roles include Senior Director, Investor Relations and Corporate Communications at Global Blood Therapeutics, and Director, Communications at Aimmune Therapeutics. Early career experience includes positions at Gilead Sciences, the FDA, USDA-ARS, The Cancer Council Victoria, and USDA-APHIS. Stephanie Y. holds a Bachelor of Science in Public Relations from the University of Florida and a Master of Arts in Communications from RMIT University.